Divestiture • Life Science

Fortissimo Capital Acquires Prothya Biosolutions

On January 1, 2021, growth capital firm Fortissimo Capital acquired life science company Prothya Biosolutions from Sanquin Blood Supply Foundation

Acquisition Context
  • This is Fortissimo Capital’s 1st transaction in the Life Science sector.
  • This is Fortissimo Capital’s 1st transaction in Belgium.
Investment Fate
  • Prothya Biosolutions was sold to a strategic buyer in 2025.

Explore All 789 Divestiture Life Science Deals - Search the Database Free


M&A Deal Summary

Date January 1, 2021
Target Prothya Biosolutions
Sector Life Science
Buyer(s) Fortissimo Capital
Sellers(s) Sanquin Blood Supply Foundation
Deal Type Divestiture

Target Company

Prothya Biosolutions

Brussels, Belgium
Prothya Biosolutions produces and exports a broad range of pharmaceuticals for patients throughout the world. Prothya Biosolutions is based in Brussels, Belgium.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Fortissimo Capital

Tel Aviv, Israel

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 2004
PE ASSETS 2.7B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Fortissimo Capital is a private equity firm that targets investments in private and public Israeli companies. The Firm looks to invest in technology-based and industrial companies that require capital to expand. Fortissimo focuses on companies operating in high growth markets with proven sales, consistent revenue streams, and strong customer bases. Fortissimo will consider a variety of transaction situations including spinouts, selling shareholders, growth capital financings, and special situations. Fortissimo Capital was formed in 2004 and is based in Tel Aviv.


Deal Context for Buyer #
Overall 30 of 39
Sector: Life Science 1 of 2
Type: Divestiture 3 of 3
Country: Belgium 1 of 1
Year: 2021 1 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-01 Cello

Holon, Israel

Cello develops one of the world’s first parking payment apps and offering cutting-edge IoT-based solutions for both public and private parking needs. Cello is based in Holon, Israel.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-09 Kramer Electronics

Airport City, Israel

Kramer Electronics designs, develops and manufactures audiovisual systems. Kramer Electronics offers an extensive and innovative Pro AV product portfolio for Corporate, Education, Houses of worship, Government, Entertainment, Health care and more. Kramer Electronics was founded in 1981 and is based in Airport City, Israel.

Buy -

Seller Profile 1

SELLER

Sanquin Blood Supply Foundation

Amsterdam, Netherlands

Category Company
Founded 1998
Sector Life Science
DESCRIPTION

Sanquin Blood Supply Foundation provides blood services on a not-for-profit basis. Sanquin offers blood, and conducts scientific research in the fields of blood transfusion medicine and immunology, applying this knowledge to the development and production of a range of pharmaceutical and diagnostic services. Sanquin Blood Supply Foundation was founded in 1998 and is based in Amsterdam, Netherlands.


Deal Context for Seller #
Overall 1 of 2
Sector: Life Science 1 of 2
Type: Divestiture 1 of 2
Country: Belgium 1 of 1
Year: 2021 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-29 Essange Reagents

Amsterdam, Netherlands

Essange Reagents is a producer in the field of hematology and immunology reagents, supplying tests to laboratories for medical diagnostics and research. Essange Reagents is based in Amsterdam, Netherlands.

Sell -

Explore Related M&A Activity